The Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

His proposal could prevent pharmacy benefit managers from inflating medication costs by banning spread pricing.

Ozempic, Rybelsus and Wegovy. These three medications are Type 2 diabetes drugs that are also used to treat cardiovascular disease and obesity. Between October 2023 and October 2024, the cost of the ...

The Department of Health and Human Services Office of Inspector General Feb. 18 released a report that found about 40% of Medicare enrollees who began opioid use disorder treatment with buprenorphine ...

The Trump administration is moving forward with the defense of a Biden-era plan that allows Medicare to negotiate drug prices ...